PSR SUPPLIER REPORT
Independent review of supplier documentation, analytical testing evidence, lot traceability, pricing visibility, and company transparency.
REPORT STATUS
Initial Review
LAST REVIEWED
September 2026
SUPPLIER TYPE
Research-use supplier
LOCATION LISTED
Bucharest, Romania
AFFILIATE DISCLOSURE
PSR may receive compensation when visitors access CertaPeptides through certain referral links. Affiliate relationships do not determine PSR scores, methodology, findings, rankings, or editorial conclusions.
PRELIMINARY PSR ASSESSMENT
95 / 100 · STRONG TRANSPARENCY
WEIGHTED OVERALL PSR TRANSPARENCY SCORE
95 / 100
Preliminary assessment pending continued documentation review. Scores reflect transparency evidence and are not a certification, guarantee, safety determination, or human-use recommendation.
DOCUMENTATION QUALITY · 25%
96 / 100
TESTING EVIDENCE · 25%
90 / 100
LOT TRACEABILITY · 20%
97 / 100
PRICING TRANSPARENCY · 15%
95 / 100
SUPPLIER TRANSPARENCY · 15%
96 / 100
EXECUTIVE SUMMARY
A neutral reading of the public record.
A key strength is that Certa clearly distinguishes between supplier specifications and independent third-party testing rather than presenting every product as independently tested. Its FAQ states that CertaPeptides is a reseller, does not operate an in-house laboratory, and uses Janoshik Analytical for selected lots while supplier batch specifications cover the broader catalog.
The strongest transparency signals are batch-code verification, direct access to third-party lab evidence, clear disclosure of what is and is not independently tested, public company information, and highly visible pricing. Areas for further review include the consistency of third-party testing coverage across product lines and the distinction between supplier-spec data and measured independent results.
PSR’s assessment reflects documentation transparency and evidence availability. It is not a certification or determination of product safety, efficacy, regulatory status, or suitability for human use.
01 / DOCUMENTATION REVIEW
Documentation Quality
POSITIVE EVIDENCE
• Public COA / quality archive
• Batch-number verification system
• Lab report-code verification
• Supplier specifications across product lines
• Independent Janoshik reports on selected lots
• Direct third-party verification pathway
• Product-specific batch information
• Public company registration details
• Public contact information
• Public pricing and volume discounts
• Clear disclosure that Certa is a reseller
• Clear disclosure that testing is not performed in-house
OPEN QUESTIONS
• How frequently each product line receives independent third-party testing
• Whether every active inventory lot can be matched to either a supplier specification or Janoshik report
• How supplier batch specifications are generated and independently validated
• Whether historical batch records remain permanently accessible
• Which testing panels are included beyond HPLC purity and identity on individual lots
• How often selected-lot testing cycles are refreshed
PSR OBSERVATION
CertaPeptides demonstrates unusually strong documentation transparency by clearly separating supplier-provided specifications from independent third-party measurements. PSR views this distinction as a positive transparency signal because it allows researchers to understand which claims are independently measured and which originate from supplier specifications.
02 / TESTING EVIDENCE
CertaPeptides publishes independent third-party reports from Janoshik Analytical for selected lots and separately publishes supplier batch specifications across the broader catalog. Its public quality archive includes batch identifiers, HPLC purity results, measured content, test dates, report codes, and direct pathways to verify independent reports at the issuing laboratory.
Public Quality Archive — Present · Batch Verification — Present · Janoshik Reports — Present · Supplier Batch Specifications — Present · HPLC Purity — Present on applicable independent reports · Measured Content — Present on many reports · Lab Report Code — Present · External Lab Verification — Available
PSR NOTE
CertaPeptides provides unusually strong testing transparency because it clearly separates independent Janoshik measurements from supplier batch specifications. PSR gives greater evidentiary weight to the independently verifiable reports and does not treat supplier specifications as equivalent to third-party testing.
SUPPLIER-STATED
Claims or specifications originating from CertaPeptides or its upstream supplier that PSR has not independently substantiated through a third-party laboratory report.
DOCUMENT OBSERVED
Information directly displayed in CertaPeptides’ public quality archive, batch-verification system, company pages, or independently linked laboratory reports.
PSR CONCLUSION
A preliminary interpretation based on the evidence available at the time of review, with independent laboratory reports weighted more heavily than supplier specifications.
03 / SAMPLE COA OBSERVATIONS
CERTIFICATE 01 / DOCUMENT OBSERVED
Reta 20 mg
Report Number
#212146
Report Code
TSIS765B8HAH
Test Date
August 6, 2026
HPLC Purity
99.850%
Measured Content
19.72 mg
Label Recovery
98.6% of label
Method
HPLC purity + identity
CERTIFICATE 02 / DOCUMENT OBSERVED
BPC-157 20 mg
Report Number
#200860
Test Date
July 25, 2026
HPLC Purity
99.623%
Measured Content
21.56 mg
Label Recovery
107.8% of label
Verification Status
Independent report publicly listed
These observations apply only to the specific submitted samples represented by the cited laboratory reports. PSR does not generalize individual Janoshik results to every CertaPeptides product or batch. Measured content above or below the nominal label amount is reported as documented and should not be interpreted by PSR as evidence of safety, dosing suitability, or regulatory compliance.
04 / LOT TRACEABILITY
Lot Traceability
CertaPeptides provides one of the strongest lot-traceability systems PSR has reviewed so far. Product lots are tied to batch identifiers, public verification tools, supplier batch specifications, and on selected lots independent Janoshik Analytical reports with corresponding report numbers and verification codes.
Positive Indicators
• Batch code printed on product labeling
• Public batch-verification system
• Verification by batch number or report code
• Supplier batch specifications tied to specific lots
• Independent Janoshik reports tied to selected lots
• Report number and verification code publicly displayed
• Product identity, purity, content, and test date linked to the lot
• Historical verification records publicly accessible
Limitation
PSR has not independently observed the complete chain of custody from upstream manufacturing through laboratory submission, warehousing, and final fulfillment. Certa’s batch-verification architecture is exceptionally strong from a documentation standpoint, but it does not by itself establish independently verified end-to-end custody.
05 / PRICING VISIBILITY
Pricing Visibility
CertaPeptides provides very strong public pricing visibility. Product pages display exact euro pricing, available strengths, quantity-based discounts, shipping thresholds, shipping costs, and payment-method information without requiring an account. This makes standardized supplier-to-supplier comparison relatively straightforward.
PSR Observation — CertaPeptides provides excellent pricing transparency. Researchers can review list prices, size options, volume discounts, shipping thresholds, and payment limitations before checkout, with no account required to access core pricing information. This supports one of the strongest pricing-transparency scores in the current PSR supplier set.
06 / COMPANY & SUPPLIER TRANSPARENCY
Legal Entity — CERTALAB S.R.L. · Registration Number (CUI) — 54169956 · Trade Register — J2026014773006 · Country — Romania, EU · Public Bucharest Address — Available · Public Email — Available · Public Phone — Available · Live Chat — Available · Terms / Privacy / Returns Policies — Available · Research-Use Disclaimer — Available
PSR Observation — CertaPeptides provides unusually strong public company transparency. The supplier identifies the operating legal entity, registration numbers, Bucharest address, support email, phone number, legal-policy pages, and research-use restrictions directly on the public website. This level of business-identification detail materially strengthens the Supplier Transparency score.
ITEMS REQUIRING CONTEXT
CertaPeptides describes itself as a reseller rather than a manufacturer · Supplier specifications and independent Janoshik reports should remain clearly distinguished · Fulfillment and upstream manufacturing relationships are not fully independently mapped by PSR
07 / EVIDENCE CLASSIFICATION
VERIFIED IN PUBLIC DOCUMENTATION — PSR directly observed CertaPeptides’ public quality archive, batch-verification system, supplier batch specifications, independently linked Janoshik reports on selected lots, public pricing, volume discounts, company-registration details, contact information, legal-policy pages, and research-use disclosures. SUPPLIER-STATED — CertaPeptides states that supplier batch specifications cover the broader catalog, selected lots receive independent Janoshik testing, products are sourced through upstream suppliers, and Certa operates as a reseller rather than an in-house manufacturer or laboratory. NOT DETERMINED — PSR has not independently established complete chain of custody from upstream manufacturing through laboratory submission and final fulfillment, independently validated every supplier batch specification, or confirmed the testing frequency applied across every product line and active lot.
08 / BALANCED ASSESSMENT
DOCUMENTATION STRENGTHS
Public quality archive · Batch-verification system · Supplier batch specifications · Independently linked Janoshik reports on selected lots · Report numbers and verification codes · Strong lot-level traceability · Public pricing and volume discounts · Public legal-entity information · Public contact details · Clear reseller disclosure · Clear separation between supplier specifications and third-party testing
AREAS FOR FURTHER REVIEW
Complete chain-of-custody verification · Independent testing frequency across every product line · Validation of supplier batch specifications · Long-term historical archive availability · Upstream manufacturing transparency · Whether every active lot can be matched to current documentation
PSR ASSESSMENT
Preliminary PSR Transparency Score: 95 / 100 — Excellent Transparency
CertaPeptides demonstrates one of the strongest transparency frameworks in the current PSR supplier set. Its public batch-verification system, supplier specifications, independently verifiable Janoshik reports on selected lots, clear legal-entity disclosure, public pricing, and explicit distinction between supplier-provided and third-party evidence support an Excellent preliminary transparency rating.
The primary limitations are not a lack of documentation, but the boundaries of that documentation. PSR has not independently verified complete chain of custody, the testing frequency applied across every active product line, or the underlying generation of all supplier batch specifications. PSR therefore does not treat Certa’s documentation as proof of product safety, efficacy, regulatory compliance, or suitability for human or animal use.
09 / SOURCES REVIEWED
CertaPeptides official website - CertaPeptides Quality Framework - CertaPeptides COA archive - CertaPeptides batch-verification tool - CertaPeptides contact/company-information page - CertaPeptides FAQ - CertaPeptides affiliate program page - Janoshik Analytical reports linked through CertaPeptides
DISCLAIMER
PSR evaluates supplier transparency and publicly available documentation for informational and research purposes. A PSR score is not a certification, laboratory guarantee, medical recommendation, safety determination, regulatory approval, or guarantee of product identity, purity, efficacy, legality, or suitability for human or animal use. Independent laboratory results apply only to the specific submitted samples represented by the reviewed reports. Supplier batch specifications are not treated by PSR as equivalent to independent third-party testing.